Compass Therapeutics, Inc. - Current Ratio

The Current Ratio as of June 2026 (TTM) for Compass Therapeutics, Inc. (CMPX) is 19.04

According to Compass Therapeutics, Inc.’s latest financial reports and current stock price. The company's current Current Ratio is 19.04. This represents a change of 27.90% compared to the average of 14.88 of the last 4 quarters.

Compass Therapeutics, Inc. (CMPX) Historical Current Ratio (quarterly & annually)

How has CMPX Current Ratio performed in the past?

The mean historical Current Ratio of Compass Therapeutics, Inc. over the last ten years is 11.27. The current 19.04 Current Ratio has changed 16.79% with respect to the historical average. Over the past ten years (40 quarters), CMPX's Current Ratio was at its highest in in the March 2024 quarter at 40.74. The Current Ratio was at its lowest in in the March 2019 quarter at 0.

Compass Therapeutics, Inc. (CMPX) Current Ratio by Quarter and Year

Discovering the peaks and valleys of Compass Therapeutics, Inc. Current Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Compass Therapeutics, Inc. (CMPX) Average Current Ratio

How has CMPX Current Ratio performed in the past?

The current Current Ratio of Compass Therapeutics, Inc. (CMPX) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages

Compass Therapeutics, Inc. (CMPX) Current Ratio vs. Peers

How is CMPX’s Current Ratio compared to its peers?

Compass Therapeutics, Inc.’s Current Ratio is less than Fulcrum Therapeutics, Inc. (34.33), greater than 4D Molecular Therapeutics, Inc. (9.34), greater than Ocugen, Inc. (1.86), greater than Bicycle Therapeutics plc (12.66), greater than Gossamer Bio, Inc. (2.20), greater than Lexicon Pharmaceuticals, Inc. (18.79), less than Monopar Therapeutics Inc. (56.04), less than Corvus Pharmaceuticals, Inc. (19.81), greater than KalVista Pharmaceuticals, Inc. (5.58), greater than Omeros Corporation (3.03),

Build a custom stock screener for Compass Therapeutics, Inc. (CMPX) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Compass Therapeutics, Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Compass Therapeutics, Inc. (CMPX) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Compass Therapeutics, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.